Skip to content

Feasibility of High-Intensity Interval Nordic Walking in Patients With Coronary Artery Disease

Coronary Artery Disease

Coronary revascularization, such as heart bypass surgery (CABG) and percutaneous coronary intervention (PCI \[inserting a stent to open up blood vessels\]) improve survival for people with coronary artery disease. Yet, many patients suffer from poor physical and mental health after coronary revascularization. Traditional cardiac rehabilitation involving moderate-to-vigorous intensity continuous training (MICT) improves physical and mental health. However, alternative exercise programs, such as high-intensity interval training (HIIT) and Nordic walking may provide superior benefits. Nordic walking is like Nordic skiing but uses specifically designed poles for walking. Nordic walking involved core, upper and lower body muscles, resulting in greater energy expenditure while reducing loading stress at the knee. To date, HIIT used in cardiac rehabilitation settings has focused on lower body (e.g., leg cycling). The investigators are not aware of HIIT protocols that target both upper and lower body at the same time. An exercise program that combines HIIT and Nordic walking (HIIT-NoW) may offer an alternative time-efficient whole-body exercise to improve physical and mental health. This study will test if HIIT-NoW can be an alternative exercise option to improve physical and mental health in patients with coronary artery disease.

null

Participation Requirements

  • Sex:

    ALL
  • Eligible Ages:

    40 and up

Participation Criteria

Inclusion Criteria:

* patients with coronary artery disease treated with PCI or CABG;
* willing to come onsite for exercise sessions;
* able to perform a cardiopulmonary exercise testing (CPET); and,
* at least 40 years of age.

Exclusion Criteria:

* currently participating in a CR program;
* unstable angina or established diagnosis of atrial fibrillation, chronic obstructive pulmonary disease, severe mitral or aortic stenosis, or hypertrophic obstructive cardiomyopathy; or,
* unable to return for 10-week follow-up visit.

Study Location

University of Ottawa Heart Institute
University of Ottawa Heart Institute
Ottawa, Ontario
Canada

Contact Study Team

Primary Contact

Jennifer L Reed, PhD

[email protected]
6136967392
Backup Contact

Matheus Mistura, MSc, BSc

[email protected]
6136967000
Study Sponsored By
Ottawa Heart Institute Research Corporation
Participants Required
More Information
Study ID: NCT05434117